Holen Sie sich die Stockscreener-App
1.75
1.13%
-0.02
Finanzdaten der Zentalis Pharmaceuticals Inc-Aktie (ZNTL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | 26.86 | - | - |
Operating Expenses
|
20.97%
36.06
|
45.62 | 76.71 | 51.43 | 65.15 |
| Operating Income/Loss |
20.97%
-36.06
|
-45.62 | -49.85 | -51.43 | -65.15 |
| Income/Loss From Continuing Operations Before Tax |
44.34%
-26.87
|
-48.28 | -47.68 | -40.19 | -88.01 |
| Income Tax Expense/Benefit |
-
|
- | -0.205 | -0.027 | 0.266 |
| Income/Loss From Continuing Operations After Tax |
44.34%
-26.87
|
-48.28 | -47.47 | -40.16 | -88.28 |
|
Net Income/Loss
|
44.34%
-26.87
|
-48.28 | -47.47 | -40.16 | -88.28 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.44%
71.99
|
71.68 | 0.063 | 71.11 | 71.04 |
| Diluted Average Shares |
0.44%
71.99
|
71.68 | 0.063 | 71.11 | 71.04 |
| Basic Earnings Per Share |
44.78%
-0.37
|
-0.67 | -0.66 | -0.56 | -1.24 |
| Diluted Earnings Per Share |
44.78%
-0.37
|
-0.67 | -0.66 | -0.56 | -1.24 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):